Page last updated: 2024-09-03

ro 22-1319 and Dementia Praecox

ro 22-1319 has been researched along with Dementia Praecox in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kirkpatrick, B; Tamminga, CA; Thaker, GK; Wagman, AM	1
Berger, PA; Cohen, JD; Marder, S; Stahl, SM; Van Putten, T	1

Trials

1 trial(s) available for ro 22-1319 and Dementia Praecox

Article	Year
The efficacy of piquindone, a new atypical neuroleptic, in the treatment of the positive and negative symptoms of schizophrenia. Journal of clinical psychopharmacology, 1987, Volume: 7, Issue:5 Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Clinical Trials as Topic; Double-Blind Method; Humans; Isoquinolines; Male; Middle Aged; Schizophrenia	1987

Other Studies

1 other study(ies) available for ro 22-1319 and Dementia Praecox

Article	Year
Alterations in sleep polygraphy after neuroleptic withdrawal: a putative supersensitive dopaminergic mechanism. Biological psychiatry, 1989, Volume: 25, Issue:1 Topics: Adult; Antipsychotic Agents; Brain; Chronic Disease; Dyskinesia, Drug-Induced; Electroencephalography; Haloperidol; Humans; Isoquinolines; Male; Prolactin; Reaction Time; Receptors, Dopamine; Receptors, Dopamine D2; Schizophrenia; Sleep Stages; Sleep, REM; Substance Withdrawal Syndrome	1989

Article

Year

Alterations in sleep polygraphy after neuroleptic withdrawal: a putative supersensitive dopaminergic mechanism.

Biological psychiatry, 1989, Volume: 25, Issue:1

Topics: Adult; Antipsychotic Agents; Brain; Chronic Disease; Dyskinesia, Drug-Induced; Electroencephalography; Haloperidol; Humans; Isoquinolines; Male; Prolactin; Reaction Time; Receptors, Dopamine; Receptors, Dopamine D2; Schizophrenia; Sleep Stages; Sleep, REM; Substance Withdrawal Syndrome

1989